Aptiom (eslicarbazepine acetate) is not a controlled substance. It carries no DEA scheduling, meaning it is not classified alongside drugs that have recognized potential for abuse or dependence. You can fill a prescription for Aptiom at any pharmacy without the special restrictions that apply to controlled medications, such as limits on refills or requirements for new prescriptions each month.
Why Aptiom Is Not Scheduled
The DEA places drugs into one of five schedules based on their potential for abuse, physical dependence, and accepted medical use. Aptiom has been formally evaluated on all three counts and does not meet the criteria for any schedule.
In a controlled clinical trial, recreational sedative users received Aptiom at doses ranging from the standard 800 mg up to a supratherapeutic 2,400 mg. At every dose, participants rated Aptiom’s “drug liking” significantly lower than the comparison sedative. At the standard 800 mg dose, liking scores were statistically identical to placebo. Higher doses did produce slightly more liking than a sugar pill, but the differences were minimal, ranging from about 9 to 13 points on a 100-point scale. Across nearly every measure of euphoria, feeling “high,” and willingness to take the drug again, Aptiom scored far below the active comparator.
Physical dependence has also been ruled out. A pooled analysis of ten placebo-controlled trials looked at what happened when patients stopped Aptiom abruptly rather than tapering off. Side effects in the week after stopping were low and nearly identical to rates seen with placebo. There were no reports of hallucinations, autonomic disturbances, or any pattern of withdrawal symptoms. The researchers concluded there was no evidence of a withdrawal syndrome.
How It Compares to Other Seizure Medications
Not all epilepsy drugs share this non-controlled status. Several commonly prescribed seizure medications do carry DEA scheduling:
- Schedule III: perampanel
- Schedule IV: clobazam, clonazepam, diazepam, phenobarbital
- Schedule V: brivaracetam, cenobamate, lacosamide, pregabalin
These medications have varying degrees of recognized abuse potential, which means prescriptions may come with refill limits, require a new written prescription each time, or involve additional pharmacy checks. Aptiom does not require any of that. It falls into the same non-controlled category as many other widely used seizure drugs, including carbamazepine, lamotrigine, levetiracetam, oxcarbazepine, and valproic acid.
What Aptiom Is Used For
Aptiom is FDA-approved to treat partial-onset seizures (also called focal seizures) in patients aged 4 and older. It can be used on its own or alongside other seizure medications. Once swallowed, the tablet is converted in the body to its active form, which works by blocking certain sodium channels in the brain. These channels are responsible for the rapid electrical firing that triggers seizures, so quieting them helps prevent seizure activity from starting or spreading.
What This Means for Your Prescription
Because Aptiom is not controlled, the practical experience of filling and managing your prescription is simpler than it would be for a scheduled drug. Your doctor can call in or electronically send refills without writing a new prescription each visit. Pharmacies are not required to keep it in a locked cabinet or report dispensing to a state monitoring database. If you travel, you won’t face the same documentation requirements that apply to controlled seizure medications like clonazepam or pregabalin.
That said, Aptiom still requires a prescription. It is not available over the counter. And while it does not cause physical dependence in the way controlled substances can, stopping any seizure medication abruptly raises the risk of breakthrough seizures. A gradual dose reduction is standard practice when discontinuing epilepsy treatment, regardless of a drug’s controlled status.